Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study

Twin Res Hum Genet. 2011 Oct;14(5):417-21. doi: 10.1375/twin.14.5.417.

Abstract

microRNAs are small, non-coding RNAs that influence gene expression on a post-transcriptional level. They participate in diverse biological pathways and may act as either tumor suppressor genes or oncogenes. As they may have an effect on thousands of target mRNAs, single-nucleotide polymorphisms in microRNA genes might have major functional consequences, because the microRNA's properties and/or maturation may change. miR-196a has been reported to be aberrantly expressed in breast cancer tissue. Additionally, the SNP rs11614913 in hsa-mir-196a-2 has been found to be associated with breast cancer risk in some studies although not in others. This study evaluated the association between rs11614913 and breast cancer risk in a Caucasian case-control cohort in Queensland, Australia. Results do not support an association of the tested hsa-mir-196a-2 polymorphism with breast cancer susceptibility in this cohort. As there is a discrepancy between our results and previous findings, it is important to assess the role of rs11614913 in breast cancer by further larger studies investigating different ethnic groups.

Publication types

  • Comparative Study

MeSH terms

  • Australia
  • Breast Neoplasms / genetics*
  • Case-Control Studies
  • Cohort Studies
  • DNA, Neoplasm / genetics
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • MicroRNAs / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide / genetics*
  • Risk Factors

Substances

  • DNA, Neoplasm
  • MIRN196 microRNA, human
  • MicroRNAs